We wished to address a number of issues that are key to clinical translation in these studies, characterizing the efficacy of UC-derived CD362+ hMSCs (trademark Orbcel-C®) in a preclinical model of E. coli-induced pneumonia in the rat. This evidence concerns the gene SDC2 and pneumonia.